Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) Stock Falling -5.24% Over A Month – Any Room For Its Value To Rise?
Adaptimmune Therapeutics Plc ADR (NASDAQ:ADAP)’s traded shares stood at 0.81 million during the last session, with the company’s beta value hitting 2.50. At the close